Tech Company Financing Transactions
Edico Genome Funding Round
Edico Genome, based in San Diego, secured $22 million from Dell Technologies Capital, Axon Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/10/2017
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series B
Investors
Dell Technologies Capital (Lead Investor) (Gregg Adkin)
private investors (Greg Lucier)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12400 High Bluff Dr. 650
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Edico Genome is the developer of DRAGEN, the world's first Bio-IT processor for analyzing Next Generation Sequencing data.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pieter van Rooyen
Chief Financial Officer
Gavin Kosviner
VP - Engineering
Rami Mehio
VP - Marketing
Gavin Stone
Browse more venture capital transactions:
Prev: 5/10/2017: Microf venture capital transaction
Next: 5/10/2017: BC Platforms venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs